LINC01913 and LINC01389 as the novel diagnostic tumor markers for the early-stage renal cell carcinoma
Background: Renal cell carcinoma (RCC) ranks as the second most common urological cancer globally. Despite recent progresses, there is a low survival rate for metastatic RCC that is the consequence of advanced stage diagnosis in these patients. Therefore, it is required to find the novel markers for...
Wedi'i Gadw mewn:
| Prif Awduron: | , , , , |
|---|---|
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Elsevier
2026-01-01
|
| Cyfres: | Cancer Treatment and Research Communications |
| Pynciau: | |
| Mynediad Ar-lein: | http://www.sciencedirect.com/science/article/pii/S2468294225002254 |
| Tagiau: |
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|